Takagi H
No ORCID on file
· 13 papers in corpus
· active 1998-2023
Study types
- article 9
- other 2
Condition tags
- endometriosis 10
- adenomyosis 4
- endometrioma 3
- dysmenorrhea 1
- bladder_endometriosis 1
Top journals
Frequent coauthors
- Hiroaki Takagi 11
- Imai A 7
- Atsushi Imai 7
- Kazutoshi Matsunami 5
- Matsunami K 5
- Taketani T 5
- Ichigo S 5
- Satoshi Ichigo 5
- Matsumura Y 4
- Suzumori N 4
article
2023
OBJECTIVE: Dienogest (DNG), a fourth-generation progestin, reduces pain associated with endometriosis and uterine adenomyosis; however, it is associated with irregular uterine bleeding that can cause anemia and poor quality of life. We inve…
2021
ObjectiveSurgical treatment for patients who refuse blood transfusion due to religious beliefs is an important issue related to medical safety. Few reports have examined pulmonary surgery for these patients, and we analyzed clinical charact…
2021
PurposeWe investigate the relationships between oocyte developmental capacity and follicular size of its origin in Japanese women: those undergoing conventional IVF (cIVF) and ICSI, respectively.MethodsA total of 3377 follicles were punctur…
article
2020
PURPOSE: To identify the upstream regulators (URs) involved in the onset and pathogenesis of ovarian endometrioma. METHODS: Recently, a method called Significance-based Modules Integrating the Transcriptome and Epigenome (SMITE) that uses t…
other
2019
Aberrant DNA methylation suppresses expression of estrogen receptor 1 (ESR1) in ovarian endometrioma
BACKGROUND: In ovarian endometriomas (OE), the expression statuses of various steroid hormone receptors are altered compared with their expression statuses in eutopic endometrium (EE). For example, in OE, the expressions of estrogen recepto…
article
2015
BACKGROUND: Estrogen deprivation therapy for myoma/adenomyosis decreases bone mineral density and can only be applied in the short term, as temporizing measures in the premenopausal woman. OBJECTIVE: To examine the effects of bisphosphonate…
article
2014
Intrauterine devices (IUDs) provide highly effective, long-term, safe, reversible contraception, and are the most widely used reversible contraceptive method worldwide. The levonorgestrel-releasing IUD (LNG-IUD), originally designed for lon…
article
2014
Malignant neoplasia arising from ovarian remnants following bilateral salpingo-oophorectomy (Review)
Ovarian remnant syndrome (ORS) is a rare, but well-known gynecological complication, most often induced by difficult bilateral salpingo-oophorectomy (BSO) procedures that leave residual ovarian tissue on the pelvic wall. The most common pre…
other
2011
PURPOSE: Uterine leiomyomas are the most common benign tumors of reproductive age women, but there is no effective medical therapy to data. Aim of this study was to examine and compare the efficacy of gonadotropin-releasing hormone agonist …
article
2011
Novel [corrected] medical management of primary bladder endometriosis with dienogest: a case report.
BACKGROUND: Because of its low incidence, medical treatment of has not yet been well established although surgical excision is generally considered effective. We report the first case of primary bladder endometriosis successfully managed wi…
article
1999
ObjectiveTo explore endometriosis-related molecules in patients with use of differential display analysis.DesignProspective study.SettingNagoya City University Medical School, Nagoya, Japan.Patient(s)Women with endometriosis (n = 27) and wi…
article
1998
Changes in serum glucose levels were examined in a female with insulin-independent diabetes who received a gonadotropin-releasing hormone (GnRH) analog treatment for pelvic endometriosis. The mean blood glucose levels were higher on buserel…
article
1998
Levels of CA125, CA72-4 and CA19-9, serum markers for ovarian cancer, were measured throughout menstrual cycles in a patient with probable pelvic endometriosis. The patient had CA125 levels >1000 U ml(-1), CA72-4>10 U ml(-1) and CA19-9>150 …